Peptide Libraries TRIZ Cases

A screened sol-gel composition immobilizes probes on untreated substrates, preserving protein activity and assay specificity without surface treatment.

Segmented reaction chambers and controlled openings increase solution capacity while preventing overflow and cross-contamination.

Hydrophobicity-based peptide selection converts isobaric discovery data into label-free inclusion lists, cutting validation time in LC-MS analysis.

Microparticles with cleavable nucleic acid linkers expand split-pool library size while improving decoding and hit identification.

Natural alpha-beta TCR sequences from donor mRNA preserve thymic-selected folding and diversity, enabling stronger, more specific antigen binding.

Targeted VH mutations at positions 112, 11, and 89 plus short C-terminal extensions reduce pre-existing antibody binding and improve solubility.

A deaminase inserted into a flexible Cas9 loop keeps editing near the target base and reduces genome-wide non-target deamination.

Barcoded pseudoviral libraries enable safe, high-resolution mapping of viral entry mutations to predict treatment resistance and species adaptation.

Humanized antibody frameworks preserve bovine ultralong CDR3 binding while accommodating cysteine motifs and disulfide patterns.

Composite N-mer peptides embed overlapping x-mers to expand sequence coverage on one array and improve peptide binder discovery.

Single-domain anti-GCC binders enable CAR immune cells to more specifically detect and kill colorectal cancer cells with stronger cytokine release.

A porous pillar substrate and polymer-based coupling formulation raise peptide array density and consistency without toxic chemicals.

Multiple puromycin-like units let one mRNA capture several peptides, improving multivalent binding and peptide selection recovery.

Predesigned CDR mutation libraries narrow antibody sequence space to find higher-affinity variants while keeping library complexity manageable.

Co-compartmentalizing cyclic peptides with their encoding polynucleotides enables functional assay screening with direct sequencing-based identification.

Multi-site immunization with multiple adjuvants and lymph node B-cell harvesting boosts antigen-specific hybridomas for GPCR and ion channel targets.

Targeted DGR reverse transcription and recombineering create diverse Cas variants in vivo while controlling mutation positions and limiting nonsense mutations.

Polypeptide arrays built from cDNA templates simplify microarray production while enabling sensitive detection of breast cancer autoantibodies.

Ligand-conjugated antibody fragments improve membrane protein binding affinity and enable functional modulation during phage display screening.

Specific nitroaldolase mutations enable direct (S)-selective ketone conversion to β-nitro alcohol precursors with high yield and fewer toxic by-products.

Cyclic de novo binding polypeptides avoid disulfide mispairing while preserving high target affinity, specificity, and production quality.

Recombinant polyclonal proteins replace variable plasma antibodies with scalable, engineered SARS-CoV-2 neutralization and cleaner Fc control.

A hydrophobic seal blocks analytes from non-target tissue regions, improving spatial resolution and sequencing depth without damaging samples.

Dichloropyridinyl methyl and trifluoroethyl esters maintain tRNA aminoacylation efficiency while reducing handling, storage, and disposal risks.

A cyano group-cysteine cyclization route forms cyclic peptides with stronger membrane permeability, stability, and target binding.

Coding-tagged binding agents transfer protein identity to recording tags, enabling sensitive multiplexed analysis with less cross-reactivity.

Engineered initiator tRNA enables EF-P-assisted incorporation of D-, β-, and γ-amino acids at peptide N-termini without drop-off.

Targeted somatic hypermutation motifs shrink antibody variant libraries while raising the share of higher-affinity, stable candidates.

A diketone linchpin enables rapid aqueous pharmacophore attachment to macrocyclic peptide libraries while preserving peptide and nucleic acid integrity.

Barcode-linked viral libraries stored in cells preserve variant association for faster mutation mapping, resistance analysis, and safer handling.

Multiple-site immunization, adjuvant use, and draining lymph node harvest boost antigen-specific hybridomas for GPCRs and other hard targets.

Proline-constrained de novo binding polypeptides improve target specificity while avoiding disulfide pairing issues that can lower expression quality.

Engineered N-terminal modifiers and binders create metal-chelating peptide sites for sensitive, high-throughput sequencing beyond mass spectrometry limits.

Iterative model screening and targeted data augmentation speed combinatorial discovery while reducing local-optimum bias.

Flexible hypervariable linkers help peptide aptamers keep target binding while improving cell permeability and proteolytic stability.

Preselected canine germline VH/VL sequences improve monomeric content, thermal stability, and expression in therapeutic antibody libraries.

Embedding non-human CDR3 sequences in human framework regions enables rapid humanization and high-affinity target binding in one selection round.

The array method targets inconsistent peptide synthesis by using porous pillars and at least 98% average coupling efficiency per step.

Phage-display screening can miss DRP binders through sequence redundancy; structurally diverse scaffold libraries improve target-hit discovery.

LimF enables C-prenylation of peptides and proteins, expanding prenylated compound libraries for physiologically active peptide development.

Specific oxygen placement in adjacent unnatural amino acids helps natural translation factors improve consecutive peptide translation efficiency.

Targeted amino acid changes in ankyrin repeat capping modules address fast clearance and extend the domains’ terminal half-life.

Selected AAV capsid loops improve target-cell transduction while helping preserve production yield across liver, brain, and heart.

Machine learning ranks mutant antibodies across expression, binding, stability, and solubility to resolve trade-offs from uneven measurement data.

Cell-stored barcodes connect viral variants to phenotypes for faster mutation scanning and safer study of high-containment viruses.

Medium-sized peptides often trade membrane permeability for metabolic stability; staged cyclization creates drug-like compounds for tough targets.

Binding-only screens can miss antibodies with strong downstream function; reporter cells enable integrated multiparametric discovery.

Distinct peptide targets on microarrays simplify serology, separating natural Ebola infection antibodies from EBOV vaccine responses.

Benign aqueous reactions add pharmacophores to genetically encoded macrocyclic peptide libraries while preserving peptide and nucleic acid integrity.

Selected B-cell antibody sequences are recombinantly expressed to address plasma supply shortages and batch variation in SARS-CoV-2 treatment.

Randomized loops on a CheBc-based scaffold preserve monomeric, thermostable binding while expanding recognition across therapeutic and diagnostic targets.

Low GPCR expression and purification instability complicate antibody generation; GLP1R libraries enable high-affinity binders that modulate receptor activity.

A peptide synthesis apparatus co-localizes charged tRNA with biological assemblers for precise amino acid incorporation.